Author:
Silkina M. O,Sosnova Elena A.
Abstract
Over the past 10 years, the treatment of malignant gynecological tumors has changed dramatically. For many years, a radical approach - extended hysterectomy with appendages at any stage of tumor development of internal genital organs was considered to be the only correct approach. However, many young women want to preserve their fertile function, and in this regard, the treatment tactic was improved and optimized towards the development of organ-preserving methods for the treatment of gynecological cancer. Based on the literature studied from the MedLine database, an analytical review of information on the possibilities of organ-preserving treatment for gynecological cancers in 2013-2018 was prepared and the implementation of a successful integrated organ-preserving treatment was found to be available only at early stages of cervical, endometrial and ovarian cancer. The overall survival after treatment correlates with the histological structure of the tumor, the degree of its differentiation and involvement of the underlying tissues in the pathological process, as well as the volume of surgical intervention. In most cases, after an organ-preserving treatment, the risk of tumor recurrence is low, and a woman regains a chance to become pregnant and give birth to a healthy child.